Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Harry Werner Kirsch
Age : 55
Public asset : 26,209,915 USD
Country of residence : Unknown
Linked companies : Novartis AG

Biography of Harry Werner Kirsch 
Currently, Harry Werner Kirsch is Chief Financial Officer for Novartis AG. Mr. Kirsch is also on the board of 5 other companies. In the past Mr. Kirsch occupied the position of CFO-Global Pharmaceutical Business at Procter & Gamble Co. Mr. Kirsch received an undergraduate degree from Karlsruher Institut fŘr Technologie.


Current positions of Harry Werner Kirsch 
Holdings of Harry Werner Kirsch 
Harry Werner Kirsch : Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
More news


© 2021 People and Ownership :   
Harry Werner Kirsch : Connections 


Latest news about Harry Werner Kirsch 
07/21Novartis tops forecasts as crisis impact eases
RE
07/21NOVARTIS : profit tops expectations as pandemic impact ebbs
RE
2020Novartis upbeat as drugmakers see hospitals coping with COVID
RE
2020Novartis upbeat as drugmakers see hospitals coping with COVID
RE
2020NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
2020NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
More news